How to Build a Focused Ligand Library for Molecular Docking: Diversity, Controls, and Compound Availability
Build a focused ligand library with traceable identities, chemical diversity, target-specific controls, verified compound availability, and a versioned docking manifest.
Ligand-library design sits between the biological hypothesis and the docking run. If selection happens without explicit rules, the final ranking can be dominated by duplicate records, one dense analog series, chemically irrelevant states, unavailable compounds, or controls that were added only after the results were seen.
The practical objective is not to make the largest possible file. It is to create a traceable decision set: broad enough to test meaningful chemical alternatives, focused enough to match the target question and experimental path, and structured so that positive and negative results remain interpretable.
Start with the decision the library must support
Selection questions and defensible inclusion rules
| Question | Possible inclusion evidence | Decision to record |
|---|---|---|
| Can the protocol recover target-relevant chemistry? | Reference ligand, measured binders, measured inactive compounds, and suitable decoys. | Which records are controls and which are candidates. |
| Can the pocket accommodate alternatives to known series? | Structurally diverse analogs, scaffold alternatives, shape or interaction hypotheses, and target-family evidence. | How diversity is defined and where similarity is intentionally retained. |
| Which compounds are realistic follow-up candidates? | Current physical stock, make-on-demand status, synthesis access, assay compatibility, and identity documentation. | What availability means, when it was checked, and what evidence confirms it. |
| Which chemical space is outside scope? | Binding-site dimensions, required mechanism, incompatible elements or states, assay constraints, and project-specific chemistry rules. | Exclusion rules fixed before scores are inspected. |
A project may pursue more than one question, but each compound should have a recorded reason for inclusion. “It was in the download” is provenance, not a selection rationale.
Resolve compound identity before generating docking states
Identity fields to preserve
| Field | Why it belongs in the library record |
|---|---|
| Source database, record identifier, release, and retrieval date | Allows the original record and its historical context to be recovered. |
| Canonical structure identifiers | SMILES, standard InChI, and InChIKey support deduplication and cross-resource mapping without replacing the source record. |
| Parent, salt, mixture, and component relationship | Prevents a purchasable material from being confused with the molecular species selected for docking. |
| Defined stereochemistry | Distinguishes an exact stereoisomer from an unspecified or racemic record. |
| Modeled protonation, tautomeric, and charge state | Records the actual electrostatic and geometric hypothesis presented to the receptor. |
| Preparation transformation log | Connects the retrieved structure to every generated three-dimensional docking input. |
PubChem exposes both submitted substance records and standardized compound records, and its documented standardization operation can modify components or neutralized forms depending on the request [2]. That makes standardization useful, but not silent: retain the incoming structure and the exact transformed structure. Before docking, apply the ligand preflight checklist to every selected state.
Combine evidence sources instead of trusting one collection
Useful source roles in a focused library
| Source role | What it can contribute | What must still be checked |
|---|---|---|
| Curated bioactivity resource | Target-linked activity measurements, assay context, compounds, and literature provenance. ChEMBL is designed for this role [1]. | Target mapping, assay type, relation operators, units, confidence, duplicates, and primary publication. |
| Public chemical information resource | Cross-referenced structures, identifiers, depositor records, properties, annotations, and programmatic retrieval. PubChem serves many of these use cases [2]. | Which depositor supplied the record and whether the standardized compound represents the intended material. |
| Purchasable or make-on-demand catalog aggregation | Searchable chemical space connected to vendor or synthesis routes. ZINC20 was built around purchasable and make-on-demand molecules [3]. | Current fulfillment status, lead time, exact stereochemistry, material form, and supplier confirmation. |
| Internal or collaborator collection | Known sample identity, local assay history, project-specific chemistry, and immediate testability. | Purity, storage, provenance, legal access, and whether the modeled structure matches the physical sample. |
No database is a complete truth layer. Use stable identifiers to connect records, preserve conflicting annotations, and resolve the conflict against the original assay, supplier, or physical sample before it affects the shortlist.
Preserve diversity without discarding relevant analogs
A practical diversity design
| Layer | Purpose | Implementation record |
|---|---|---|
| Reference chemistry | Retain known ligands and close analogs needed to test pose recovery and local structure-activity hypotheses. | Reference series, activity source, similarity method, and reason each analog remains. |
| Scaffold diversity | Avoid allowing one populous chemotype to consume the candidate budget. | Scaffold definition, clustering or grouping method, threshold, and representatives selected per group. |
| Physicochemical coverage | Expose size, charge, lipophilicity, flexibility, and hydrogen-bond ranges that may interact with the protocol. | Descriptors, calculation software or source, ranges, and any target-specific exclusions. |
| Shape and interaction hypotheses | Represent distinct ways to occupy the pocket or satisfy required interaction geometry. | Pharmacophore, shape, substructure, or expert-selection rule and its provenance. |
| Experimental diversity | Ensure the eventual test set can distinguish several hypotheses rather than repeat one answer. | Acquisition, solubility, assay, and information-gain considerations kept separate from docking rank. |
Large make-on-demand collections expand accessible scaffold and shape diversity [3], and a recent controlled comparison found that a much larger virtual library produced more hits and new chemotypes for one AmpC campaign [5]. Those results support the value of broader chemical space, not a universal instruction to dock every available molecule. A focused screen should preserve the diversity needed for its question while remaining compatible with computation, review, acquisition, and experimental testing.
Add controls that can challenge the protocol
Control roles in a docking library
| Control | Question it can test | Important limitation |
|---|---|---|
| Co-crystal or reference ligand | Can the preparation, box, and search settings recover a relevant pose? | One successful redocking case does not establish performance across new chemotypes. |
| Measured active ligands | Does the protocol rank or pose known target-relevant chemistry plausibly? | Closely related actives can make enrichment look stronger than performance across diverse chemistry. |
| Measured inactive compounds | Can the workflow separate tested nonactivity from known activity under comparable assay conditions? | “Inactive” depends on concentration, assay, endpoint, and detection limit. |
| Property-matched decoys | Does the method enrich known ligands over molecules with similar bulk properties but dissimilar topology? | A computational decoy is not experimentally proven inactive and may introduce benchmark bias. |
| Process controls | Are identifiers, states, failures, outputs, and analysis rules preserved consistently? | Operational traceability does not establish predictive accuracy. |
DUD-E was created to improve ligand diversity, property matching, charge matching, and decoy mapping for retrospective docking benchmarks [4]. Its design also illustrates why the control set is part of the experiment: enrichment depends on both the known ligands and the background chosen for comparison. Use target-specific controls and document their limitations before freezing the docking validation protocol.
Treat compound availability as dated evidence
Availability states worth separating
| Status | What it means | Evidence to retain |
|---|---|---|
| Physically in hand | A specific sample is accessible to the project. | Container or inventory identifier, supplier or synthesis source, lot, purity evidence, amount, storage, and check date. |
| Supplier-listed in stock | A supplier reports current stock for an exact catalog item. | Supplier, catalog ID, material form, region, quoted stock, price or quote reference, and timestamp. |
| Make on demand | A supplier offers to synthesize the enumerated compound. | Supplier ID, route or collection, fulfillment terms, estimated lead time, and date verified. |
| Synthesis feasible in project | A chemist has accepted a plausible route within local constraints. | Route assessment, required materials, decision owner, and unresolved risk. |
| Database listed only | A chemical record exists, but access to material is unconfirmed. | Database identifier and an explicit “availability unverified” label. |
ZINC20 demonstrates how a database can connect virtual chemical space to in-stock and make-on-demand catalogs [3]. Even then, availability is not timeless. Verify the exact catalog item again before purchase or assay nomination, and never infer physical stock solely from a chemical database record.
Create a versioned manifest before batch docking
Minimum focused-library manifest
| Manifest group | Fields to retain |
|---|---|
| Library identity | Name, version, creation date, owner, target, pocket hypothesis, purpose, and frozen selection rules. |
| Source identity | Source name and version, source record, canonical identifiers, original structure, retrieval date, and license or access notes. |
| Chemical representation | Parent/material relationship, stereochemistry, protonation and tautomer state, prepared structure, transformations, and software versions. |
| Selection role | Candidate, known active, measured inactive, decoy, reference ligand, diversity group, and reason for inclusion or exclusion. |
| Availability | Access state, supplier or local sample, catalog or inventory identifier, material form, date checked, and uncertainty. |
| Execution status | Preflight outcome, preparation outcome, docking outcome, failure reason, pose file, and result identifier. |
AutoDock Vina documents sequential batch docking through its
--batch option and writes ligand-specific outputs [6].
That execution model becomes scientifically useful only when each
input filename remains mapped to the manifest. The BioChemIntelli
guide to traceable AutoDock Vina batch docking
covers the execution record in detail.
A staged route from library design to experiment
| Stage | Primary decision | Exit condition |
|---|---|---|
| 1. Control panel | Can the receptor, preparation, box, scoring method, and search settings support the intended interpretation? | Predeclared target-specific checks pass, fail, or trigger protocol revision. |
| 2. Representative focused set | Do relevant chemotypes, diverse candidates, and chemical states execute cleanly and produce reviewable poses? | Failures and artifacts are understood; the manifest and review rules remain usable. |
| 3. Planned expansion | Which additional analog, scaffold, property, or availability regions would add information? | Expansion follows a documented gap rather than an arbitrary desire for more rows. |
| 4. Experimental nomination | Which candidates balance pose plausibility, diversity, access, assay readiness, and information gain? | A traceable shortlist moves to procurement or testing with independent controls. |
After docking, use the separate guide to select compounds for experimental testing. Library design determines what the screen can learn; post-docking selection determines which hypotheses are worth testing next.
Where MolNexus fits in a focused-library workflow
MolNexus can support the local docking stage after the focused ligand library and its scientific rules have been defined. The current MolNexus 0.1.1 Windows desktop application connects visible ligand and receptor preparation review, ligand preflight, interaction-box setup, AutoDock Vina 1.2.7 execution with Vina or Vinardo scoring, batch handling, pose inspection, local SQLite job history, and scientific exports.
MolNexus does not search ChEMBL, PubChem, ZINC, or supplier catalogs; choose the biological question; design chemical diversity; certify that a compound is available; or determine experimental activity. Those decisions belong in the library manifest and the downstream experimental plan. The paid offer is for one Windows PC at a time and is available now; a free two-docking trial is also available.
For an individual researcher, the product-fit question is whether a guided local workspace makes the selected library easier to prepare, execute, inspect, and retain. For a laboratory, it is whether that documented one-PC workflow fits the method and evidence handoff; team and institutional terms are not currently published.
Frequently asked questions
References
- Barbara Zdrazil, Eloy Felix, Fiona Hunter, Emma J. Manners, James Blackshaw, et al.. The ChEMBL Database in 2023: a drug discovery platform spanning multiple bioactivity data types and time periods Nucleic Acids Research (2024) DOI: 10.1093/nar/gkad1004 Current peer-reviewed description of ChEMBL bioactivity content, curation, sources, target coverage, and drug-discovery uses.
- Sunghwan Kim, Jie Chen, Tiejun Cheng, Asta Gindulyte, Jia He, Siqian He, et al.. PubChem 2023 update Nucleic Acids Research (2023) DOI: 10.1093/nar/gkac956 Authoritative description of PubChem data sources, identifiers, programmatic access, and the documented standardization operation.
- John J. Irwin, Khanh G. Tang, Jennifer Young, Chinzorig Dandarchuluun, Benjamin R. Wong, et al.. ZINC20-A Free Ultralarge-Scale Chemical Database for Ligand Discovery Journal of Chemical Information and Modeling (2020) DOI: 10.1021/acs.jcim.0c00675 Original database paper describing purchasable and make-on-demand chemical space, analog search, and scaffold and shape diversity.
- Michael M. Mysinger, Michael Carchia, John J. Irwin, and Brian K. Shoichet. Directory of Useful Decoys, Enhanced (DUD-E): Better Ligands and Decoys for Better Benchmarking Journal of Medicinal Chemistry (2012) DOI: 10.1021/jm300687e Original DUD-E paper explaining target-specific active and decoy sets, diversity, property matching, charge matching, and known benchmark limitations.
- Fan Liu, Olivier Mailhot, Ian S. Glenn, Samuel F. Vigneron, Valeria Bassim, et al.. The impact of library size and scale of testing on virtual screening Nature Chemical Biology (2025) DOI: 10.1038/s41589-024-01797-w Original controlled comparison of larger and smaller docking libraries and the effect of experimental testing scale for specific targets.
- AutoDock Vina project. Docking in batch mode AutoDock Vina 1.2.0 documentation Official documentation for sequential docking of multiple ligands with the Vina batch option and ligand-specific outputs.